Real-World Clinical Outcomes in Relapsed/Refractory Multiple Myeloma Treated With Pomalidomide Regimens
Clinical trial NCT07689006 · COMPLETED
Trial details
- NCT number
- NCT07689006
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-12-23
- Primary completion
- 2025-03-28
- Enrollment
- 341
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.